Search - tctmd.com

Displaying 801 - 820 of 1143

Sort: Relevancy | Date

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Presentation LAA 2017

Watchman: Complication Frequency, Prevention, Recognition, and Management

Presenter: Jacqueline Saw

July 21, 2017

Presentation LAA 2017

Can CT Identify the Optimal Location for LAA Puncture and Closure?

Presenter: Jacqueline Saw

July 21, 2017

Presentation LAA 2017

Case Vignettes in Complex Anatomy

Presenter: Matthew J. Price

July 21, 2017

Presentation LAA 2017

Relational Anatomy of the Septum and Left Atrial Appendage

Presenter: Mark Reisman

July 21, 2017

Presentation LAA 2017

Real-World Outcomes in Anticoagulation Indicated and Contraindicated Patients

Presenter: Horst Sievert

July 21, 2017

Watchman #1: Data Synthesis from RCTs and U.S. Registries

Presentation LAA 2017

Watchman: Data Synthesis from RCTs and U.S. Registries

Presenter: David R. Holmes

July 21, 2017

Presentation LAA 2017

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

Presenter: Shephal Doshi

July 21, 2017

Presentation LAA 2017

Changing My Transseptal Puncture Location Simplified My LAA Occlusion

Presenter: Dhanunjaya Lakkireddy

July 21, 2017

Presentation LAA 2017

The Spectrum of LAA Closure Devices: Similarities and Differences

Presenter: Horst Sievert

July 21, 2017

Presentation LAA 2017

Case: Complication of TSP

Presenter: Matthew J. Price

July 21, 2017

Presentation LAA 2017

What Have We Learned from Surgical LAA Closure?

Presenter: Subhasis Chatterjee

July 21, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation LAA 2017

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Presenter: Gregg W. Stone

July 21, 2017

Presentation LAA 2017

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

Presenter: M. Edip Gurol

July 21, 2017

Presentation LAA 2017

ICE for Trans-septal Puncture in an LAA Occlusion Procedure

Presenter: Brij Maini

July 21, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Combination Transcatheter Mitral Valve Interventions and LAA Occlusion Clinical and Technical Considerations

Presenter: Michael J. Mack, Fabian Nietlispach

June 15, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Advertisement

Left Atrial Appendage Occlusion as Adjunctive Therapy

Watchman: Complication Frequency, Prevention, Recognition, and Management

Can CT Identify the Optimal Location for LAA Puncture and Closure?

Case Vignettes in Complex Anatomy

Relational Anatomy of the Septum and Left Atrial Appendage

Real-World Outcomes in Anticoagulation Indicated and Contraindicated Patients

Watchman: Data Synthesis from RCTs and U.S. Registries

WATCHMAN LAA Closure: Device Description, Implantation Technique, Medications, and Follow-Up

Changing My Transseptal Puncture Location Simplified My LAA Occlusion

The Spectrum of LAA Closure Devices: Similarities and Differences

Case: Complication of TSP

What Have We Learned from Surgical LAA Closure?

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Warfarin and NOACs in Non-Valvular Atrial Fibrillation

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

The Multifaceted Etiology of Stroke: Focus on Atrial Fibrillation and PFO

ICE for Trans-septal Puncture in an LAA Occlusion Procedure

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Combination Transcatheter Mitral Valve Interventions and LAA Occlusion Clinical and Technical Considerations

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content